静脉输液与血管通路：推动全球医疗市场创新-动脉网

IV Therapy & Vein Access: Innovations Driving the Global Healthcare Market

CISION 等信源发布 2025-06-11 01:03



可切换为仅中文







Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly into the bloodstream. The global market for these technologies is growing due to increasing healthcare needs, advancements in medical devices and rising demand for efficient patient care..

静脉（IV）治疗和静脉通路在将药物、液体和营养直接输送入血液中起着至关重要的作用。由于医疗需求不断增加、医疗设备技术进步以及对高效患者护理需求的上升，这些技术的全球市场正在增长。

BOSTON

波士顿

，

June 10, 2025

2025年6月10日

/PRNewswire/ -- According to the latest study from BCC Research, the global market for

/PRNewswire/ -- 根据BCC Research的最新研究，全球市场对于

Intravenous (IV) Therapy and Vein Access

静脉注射（IV）治疗和静脉通路

is projected to grow from

预计将以从以下水平增长：

$57.0 billion

570亿美元

in 2024 and reach

2024年并达到

$74.4 billion

744亿美元

by the end of 2029 at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2029.

到 2029 年底，从 2024 年到 2029 年的复合年增长率 (CAGR) 将达到 5.5%。

This report provides an in-depth analysis of the global IV therapy and venous access market, covering applications across various healthcare settings. It studies IV solutions, infusion pumps and venous access devices, along with the current market trends, regulations, technological advancements and regional insights.

本报告深入分析了全球静脉输液和静脉通路市场，涵盖在各类医疗环境中的应用。研究内容包括静脉输液溶液、输液泵和静脉通路设备，以及当前的市场趋势、法规、技术进步和区域洞察。

Key innovations include AI-driven ultrasound for vein access and robotic-assisted catheter placement. It also offers market projections, share analysis and emerging developments across .

关键创新包括用于静脉通路的AI驱动超声波和机器人辅助导管放置。它还提供了市场预测、份额分析以及跨领域的新兴发展。

North America

北美

，

Europe

欧洲

，

Asia-Pacific

亚太地区

, and other regions.

，以及其他地区。

The factors driving the market include:

推动市场发展的因素包括：

Aging population

老龄化人口

：

More people are living longer, leading to a higher number of older adults in society. This happens due to better healthcare, improved lifestyles and lower birth rates, affecting economies, healthcare systems and social structures.

越来越多的人寿命更长，导致社会中老年人数量增加。这是由于更好的医疗保健、改善的生活方式和较低的出生率所致，影响了经济、医疗系统和社会结构。

Growing prevalence of chronic diseases:

慢性病的患病率不断上升：

More people are living with long-term health conditions such as diabetes, heart disease and cancer. This increase is due to aging, unhealthy lifestyles and environmental factors, which put pressure on the global healthcare systems.

越来越多的人患有糖尿病、心脏病和癌症等长期健康问题。这一增长归因于老龄化、不健康的生活方式和环境因素，给全球医疗系统带来了压力。

Alternative sites and home-based medical care:

替代站点和基于家庭的医疗保健：

This allows patients to receive treatment outside hospitals, such as at home or clinics. This approach improves convenience, reduces hospital stays and lowers healthcare costs while ensuring quality care.

这使得患者可以在医院外接受治疗，例如在家中或诊所。这种方法提高了便利性，减少了住院时间，降低了医疗成本，同时确保了高质量的护理。

Rising healthcare spending in emerging markets:

新兴市场医疗支出的增长：

A considerable amount of money is being invested in hospitals, medicines and medical technology, thereby improving healthcare access, quality and innovation in developing countries.

大量资金被投入到医院、药品和医疗技术中，从而改善了发展中国家的医疗可及性、质量和创新。

Request a Sample Copy of the

请求样本副本

Intravenous (IV) Therapy and Vein Access: Global Markets report.

静脉注射（IV）治疗和静脉通路：全球市场报告。

Report Synopsis

报告概要

Report Metric

报告指标

Details

详情

Base year considered

基准年份考虑

2023

Forecast period considered

考虑的预测期

2024-2029

Base year market size

基准年市场规模

$54.4 billion

544亿美元

Market size forecast

市场规模预测

$74.4 billion

744亿美元

Growth rate

增长率

CAGR of 5.5% for the forecast period of 2024-2029

2024-2029年预测期间的复合年增长率为5.5%

Segments covered

涵盖的细分市场

Product type, application, and region

产品类型、应用和区域

Regions covered

覆盖区域

North America, Asia-Pacific, Europe, and Rest of the World (RoW)

北美、亚太、欧洲和世界其他地区 (RoW)

Countries covered

覆盖的国家

The U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea, China, Middle East, and Africa

美国、加拿大、墨西哥、法国、德国、英国、意大利、西班牙、日本、印度、澳大利亚、韩国、中国、中东和非洲

Market drivers

市场驱动因素

• Aging population.

• 人口老龄化。

• Growing prevalence of chronic diseases.

• 慢性疾病的患病率不断上升。

• Alternative site and home-based medical care.

替代场所和家庭医疗服务。

• Rising healthcare spending in emerging markets.

• 新兴市场医疗支出不断增加。

Interesting facts:

有趣的是：

AI in intravenous therapy is set to revolutionize infusion centers by significantly improving efficiency. It can reduce patient wait times by 30%, decrease staff overtime by 50%, and increase patient capacity by 15%, all while tackling staffing shortages and operational challenges. This innovation enhances both workflow efficiency and patient care..

静脉注射治疗中的人工智能将通过显著提高效率来彻底改变输液中心的运作。它可以将患者的等待时间减少30%，员工加班时间减少50%，并将患者接待能力提高15%，同时还能应对人员短缺和运营挑战。这一创新提升了工作效率和患者护理质量。

The CLOCK trial is a pioneering hybrid randomized controlled study aimed at preventing infections, blood clots, and blockages in children undergoing cancer treatment. Conducted in

CLOCK试验是一项开创性的混合随机对照研究，旨在预防接受癌症治疗的儿童感染、血栓和堵塞。该研究在

Australia

澳大利亚

and

和

New Zealand

新西兰

, it evaluates the effectiveness of T-EDTA lock solutions versus normal or heparinized saline for central venous access devices (CVADs). Additionally, the trial assesses feasibility and cost-effectiveness, setting the stage for better pediatric cancer care worldwide.

它评估了T-EDTA锁定溶液与正常或肝素化生理盐水对于中心静脉通路装置（CVAD）的有效性。此外，该试验还评估了可行性和成本效益，为全球更好的儿科癌症护理奠定了基础。

The report addresses the following questions:

报告涉及以下问题：

What is the market's projected size and growth rate?

市场的预计规模和增长率是多少？

- The global market for intravenous therapy and vein access was valued at

- 全球静脉输液治疗和静脉通路市场估值为

$54.4 billion

544亿美元

2023. The market is expected to grow at a CAGR of 5.5%, reaching about

2023年。市场预计将以5.5%的复合年增长率增长，达到约

$74.4 billion

744亿美元

by the end of 2029.

到 2029 年末。

What factors are driving the growth of the market?

哪些因素正在推动市场的增长？

- Growing aging population.

- 不断增长的老龄化人口。

- Growing prevalence of chronic diseases

- 慢性病患病率不断上升

- Growth of alternative site and home-based medical care.

- 替代站点和家庭医疗保健的增长。

- Rising health care spending in emerging markets.

- 新兴市场医疗保健支出不断增加。

What segments are covered in the market?

市场覆盖了哪些细分市场？

- The market has been segmented based on product type, application and geography.

- 市场已根据产品类型、应用和地理区域进行了细分。

Which type segment will be dominant in 2029?

2029年哪种类型细分市场将占主导地位？

- IV solutions and sets will dominate the market by the end of 2029.

- 到2029年底，静脉输液溶液和套件将主导市场。

Which region has the highest market share?

哪个地区市场份额最高？

North America

北美

holds the largest share of the market.

占据市场的最大份额。

Market leaders include:

市场领导者包括：

VYGON SAS

维贡公司

TERUMO CORP.

泰尔茂公司

PFIZER INC.

辉瑞公司

MEDTRONIC

美敦力

INTEGRATED MEDICAL SYSTEMS INC.

综合医疗系统公司

IRADIMED CORP.

艾拉迪姆公司

FRESENIUS SE & CO. KGAA

弗雷泽纽斯股份两合公司

ICU MEDICAL INC.

ICU医疗公司

COOK

库克群岛

ANGIODYNAMICS

血管动力学

BAXTER

巴克斯特

BRAUN SE

布朗股份公司

蓝光

CARDINAL HEALTH

卡地纳健康集团

WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.

威尔梅德国际工业私人有限公司

Related Reports Include:

相关报告包括：

Global Markets for Media, Sera and Reagents in Biotechnology:

全球生物技术领域中的培养基、血清和试剂市场：

The global market for media, sera, and reagents in biotechnology supports research, drug development, and cell culture growth. Increasing demand for biopharmaceuticals and advancements in life sciences are driving market expansion worldwide.

生物技术领域中的培养基、血清和试剂的全球市场支持研究、药物开发和细胞培养的发展。对生物制药需求的增加以及生命科学的进步正在推动全球市场的扩展。

Infusion Pumps and Devices: Technologies and Global Markets:

输液泵和设备：技术与全球市场：

The global market for infusion pumps and devices focuses on technologies that deliver fluids, medications, and nutrients to patients with precision. The growing demand for advanced healthcare solutions, automation, and patient safety is driving market growth globally.

全球输液泵和设备市场聚焦于精准输送液体、药物和营养的技术。随着对先进医疗解决方案、自动化和患者安全的需求不断增长，这一市场正在全球范围内扩张。

Navigate Uncertainty with Confidence

自信地应对不确定性

In times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions.

在快速变化和不确定的时代，拥有正确的洞察力可以带来巨大的不同。在BCC研究，我们在这里支持创新，帮助您保持领先。我们的定制研究报告提供了市场环境的全面、360度视角，为您提供做出明智决策所需的清晰信息。

We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights..

我们相信，及时、专业的市场情报应该为所有人所获取。因此，在有限的时间内，我们提供BCC研究报告30%的折扣，以帮助更多组织获取我们最新的数据和见解。

Purchase a

购买一个

copy of the report

报告的副本

directly from BCC Research.

直接来自BCC研究。

For further information on any of these reports or to make a purchase, contact

如需了解更多关于这些报告的信息或进行购买，请联系

info@bccresearch.com

。

About BCC Research

关于BCC研究

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

BCC Research市场研究报告提供对市场机会的客观、公正的测量和评估。我们经验丰富的行业分析师的目标是帮助您在没有噪音和炒作的情况下做出明智的商业决策。

联系我们

Corporate HQ: 50 Milk St., Ste. 16,

公司总部：牛奶街50号，16楼，

Boston, MA

马萨诸塞州波士顿

02109,

02109，

USA

美国

Email:

电子邮件：